Literature DB >> 12037022

Epstein-Barr virus (EBV) subtype in EBV related oral squamous cell carcinoma in Okinawa, a subtropical island in southern Japan, compared with Kitakyushu and Kumamoto in mainland Japan.

M Higa1, T Kinjo, K Kamiyama, T Iwamasa, T Hamada, K Iyama.   

Abstract

AIM: In Okinawa, a subtropical island located between the East China Sea and Pacific Ocean, 2000 km south of mainland Japan, the incidence of oral squamous cell carcinoma is 1.5 times higher than that seen in mainland Japan, and a large number of these patients have been reported to be infected with the Epstein-Barr virus (EBV). This study aimed to gain a better understanding of the pathogenesis of this malignancy in this area by carrying out genomic analysis of EBV.
METHODS: Fifty four patients with oral squamous cell carcinoma reported from 1997 to 1999 in Okinawa were compared with 21 and 20 patients from Kitakyushu and Kumamoto in Kyushu, mainland Japan, respectively. Diagnosis was confirmed by conventional histological examination of paraffin wax sections. EBV was detected by non-isotopic in situ hybridisation (NISH) and the polymerase chain reaction (PCR) (Bam HI-F, EBV nuclear antigen 2 (EBNA2), and latent membrane protein 1 (LMP-1) regions). Sequence analysis of the PCR products was also carried out.
RESULTS: In Okinawa, 25 patients were found to be infected with EBV type A by analysing the 3' sequence divergence of the EBNA2 genes. Six patients were positive for EBV type B, and eight for both type A and B. Therefore, type A virus infection was demonstrated in 33 of 54 patients, and type B in 14 of 54. In total, 39 of 54 patients were infected with EBV. However, the "f" variant was shown in only one patient, who was also infected with type A virus. In contrast, 97.0% of EBV type A infected patients showed a 30 bp deletion of the LMP-1 gene, but those infected with EBV type B did not. Sequence analysis of the type A virus EBNA2 gene revealed slight variations of the sequence (mutations)-(48991)G-->T and (48998)C-->A-in 18 of 33 cases compared with the B95-8 strain, and in 14 cases, in addition to these, a further mutation of (48917)T-->C was demonstrated; in the single remaining case, only one mutation at (49137)A-->G was detected. The mutations at 48991 (G-->T), and 49137 (A-->G) are associated with amino acid changes Arg-->Met and Thr-->Ala, respectively. In contrast, no mutation was seen in the EBNA2 DNA from the 14 cases of type B virus when compared with that of the Jijoye strain. In Kitakyushu and Kumamoto, only 10 of 41 patients (six in Kitakyushu and four in Kumamoto) were infected with EBV. Among them, nine patients were infected with type A virus, and only one patient from Kitakyushu was infected with type B virus. The (48991)G-->T and (48998)C-->A mutations of the EBNA2 region were demonstrated in type A virus, but the (48917)T-->C and (49137)A-->G mutations were not when compared with the B95-8 strain. In the case of type B virus no mutation was noted. A 30 bp deletion was found in these nine cases of type A, but not in type B. The sequence analysis of EBV type A in Okinawa, Kitakyushu, and Kumamoto showed slight variations when compared with B95-8, but EBV type B LMP-1 did not when compared with the Jijoye strains.
CONCLUSION: In Okinawa, EBV infection was frequently demonstrated in oral squamous cell carcinoma (p < 0.001). However, in mainland Japan there was no significant correlation between EBV and oral squamous cell carcinoma. In Okinawa, EBV type B infection is approximately 10 times more common than in the mainland. However, in these areas-Okinawa, Kitakyushu, and Kumamoto-the frequency of the "f " variant was very low, whereas a high incidence of a 30 bp deletion of LMP-1 was noted. The number of EBV (including type A and/or B) infected oral squamous cell carcinomas in Okinawa was about three times higher than that seen in the mainland, although the frequency of oral squamous carcinoma was only 1.5 times higher than that seen in the mainland. A high prevalence of type B virus infection and slight differences in the EBNA2 gene sequence in the type A virus might influence the frequency of this carcinoma in Okinawa.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12037022      PMCID: PMC1769665          DOI: 10.1136/jcp.55.6.414

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  46 in total

1.  Construction of T-vectors, a rapid and general system for direct cloning of unmodified PCR products.

Authors:  D Marchuk; M Drumm; A Saulino; F S Collins
Journal:  Nucleic Acids Res       Date:  1991-03-11       Impact factor: 16.971

2.  New type B isolates of Epstein-Barr virus from Burkitt's lymphoma and from normal individuals in endemic areas.

Authors:  L S Young; Q Y Yao; C M Rooney; T B Sculley; D J Moss; H Rupani; G Laux; G W Bornkamm; A B Rickinson
Journal:  J Gen Virol       Date:  1987-11       Impact factor: 3.891

3.  Isolation and sequencing of the Epstein-Barr virus BNLF-1 gene (LMP1) from a Chinese nasopharyngeal carcinoma.

Authors:  L F Hu; E R Zabarovsky; F Chen; S L Cao; I Ernberg; G Klein; G Winberg
Journal:  J Gen Virol       Date:  1991-10       Impact factor: 3.891

4.  Epstein-Barr virus type B in patient with T-cell lymphoma.

Authors:  T Miyashita; H Kawaguchi; M Asada; S Mizutani; T Ibuka
Journal:  Lancet       Date:  1991-04-27       Impact factor: 79.321

5.  Detection of a second widespread strain of Epstein-Barr virus.

Authors:  J W Sixbey; P Shirley; P J Chesney; D M Buntin; L Resnick
Journal:  Lancet       Date:  1989-09-30       Impact factor: 79.321

6.  Influence of the Epstein-Barr virus nuclear antigen EBNA 2 on the growth phenotype of virus-transformed B cells.

Authors:  A B Rickinson; L S Young; M Rowe
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

7.  Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23.

Authors:  F Wang; C D Gregory; M Rowe; A B Rickinson; D Wang; M Birkenbach; H Kikutani; T Kishimoto; E Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

8.  Coinfection with A- and B-type Epstein-Barr virus in human immunodeficiency virus-positive subjects.

Authors:  T B Sculley; A Apolloni; L Hurren; D J Moss; D A Cooper
Journal:  J Infect Dis       Date:  1990-09       Impact factor: 5.226

9.  Association of Epstein-Barr virus with undifferentiated gastric carcinomas with intense lymphoid infiltration. Lymphoepithelioma-like carcinoma.

Authors:  D Shibata; M Tokunaga; Y Uemura; E Sato; S Tanaka; L M Weiss
Journal:  Am J Pathol       Date:  1991-09       Impact factor: 4.307

10.  Detection and prevalence of the "f" variant of Epstein-Barr virus in southern China.

Authors:  M L Lung; W P Lam; J Sham; D Choy; Z Yong-Sheng; H Y Guo; M H Ng
Journal:  Virology       Date:  1991-11       Impact factor: 3.616

View more
  18 in total

1.  The evolution of Epstein-Barr virus inferred from the conservation and mutation of the virus glycoprotein gp350/220 gene.

Authors:  Asako Kawaguchi; Kyosuke Kanai; Yukio Satoh; Chizu Touge; Keiko Nagata; Takeshi Sairenji; Yoshitsugu Inoue
Journal:  Virus Genes       Date:  2009-01-20       Impact factor: 2.332

Review 2.  Epigenetics of oral and oropharyngeal cancers.

Authors:  Daniela Russo; Francesco Merolla; Silvia Varricchio; Giovanni Salzano; Giovanni Zarrilli; Massimo Mascolo; Viviana Strazzullo; Rosa Maria Di Crescenzo; Angela Celetti; Gennaro Ilardi
Journal:  Biomed Rep       Date:  2018-07-27

Review 3.  The extent of genetic diversity of Epstein-Barr virus and its geographic and disease patterns: a need for reappraisal.

Authors:  Cindy M Chang; Kelly J Yu; Sam M Mbulaiteye; Allan Hildesheim; Kishor Bhatia
Journal:  Virus Res       Date:  2009-07-23       Impact factor: 3.303

4.  Dual expression of Epstein-Barr virus, latent membrane protein-1 and human papillomavirus-16 E6 transform primary mouse embryonic fibroblasts through NF-κB signaling.

Authors:  Tetsuya Shimabuku; Ayumi Tamanaha; Bunta Kitamura; Yasuka Tanabe; Natsumi Tawata; Fukino Ikehara; Kazunari Arakaki; Takao Kinjo
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

5.  Primary central nervous system lymphoma expressing the human neurotropic polyomavirus, JC virus, genome.

Authors:  Luis Del Valle; Sahnila Enam; Cesar Lara; Judith Miklossy; Kamel Khalili; Jennifer Gordon
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

6.  Clinical relevance of systematic human papillomavirus (HPV) diagnosis in oral squamous cell carcinoma.

Authors:  Chloé Bertolus; Patrick Goudot; Antoine Gessain; Nicolas Berthet
Journal:  Infect Agent Cancer       Date:  2012-05-30       Impact factor: 2.965

7.  Sequence analysis of Epstein-Barr virus EBNA-2 gene coding amino acid 148-487 in nasopharyngeal and gastric carcinomas.

Authors:  Xinying Wang; Yun Wang; Guocai Wu; Yan Chao; Zhifu Sun; Bing Luo
Journal:  Virol J       Date:  2012-02-21       Impact factor: 4.099

Review 8.  Role of viruses in oral squamous cell carcinoma.

Authors:  Rashmi Metgud; Madhusudan Astekar; Meenal Verma; Ashish Sharma
Journal:  Oncol Rev       Date:  2012-09-14

Review 9.  Evidences suggesting involvement of viruses in oral squamous cell carcinoma.

Authors:  Kanupriya Gupta; Rashmi Metgud
Journal:  Patholog Res Int       Date:  2013-12-19

Review 10.  Epstein-barr virus sequence variation-biology and disease.

Authors:  Stelios Tzellos; Paul J Farrell
Journal:  Pathogens       Date:  2012-11-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.